Greenhaven Associates Inc. Takes $228.53 Million Position in Avantor, Inc. $AVTR

Greenhaven Associates Inc. bought a new position in shares of Avantor, Inc. (NYSE:AVTR) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 18,311,570 shares of the company’s stock, valued at approximately $228,528,000. Avantor makes up approximately 3.5% of Greenhaven Associates Inc.’s portfolio, making the stock its 8th largest position.

Several other hedge funds have also recently added to or reduced their stakes in AVTR. EverSource Wealth Advisors LLC boosted its stake in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC acquired a new stake in shares of Avantor in the second quarter valued at about $32,000. FNY Investment Advisers LLC purchased a new stake in Avantor during the second quarter worth $36,000. Osaic Holdings Inc. raised its position in shares of Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in Avantor by 172.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock valued at $46,000 after purchasing an additional 2,346 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity at Avantor

In other Avantor news, Director Sanjeev K. Mehra acquired 350,000 shares of Avantor stock in a transaction on Friday, December 5th. The shares were purchased at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the purchase, the director owned 350,000 shares in the company, valued at $3,881,500. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.20% of the stock is currently owned by corporate insiders.

Avantor Stock Performance

Shares of NYSE AVTR opened at $10.91 on Friday. Avantor, Inc. has a one year low of $10.62 and a one year high of $22.44. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $7.44 billion, a price-to-earnings ratio of -83.92, a PEG ratio of 3.75 and a beta of 0.93. The business has a fifty day simple moving average of $11.58 and a 200 day simple moving average of $12.41.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.01). The firm had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 EPS. Sell-side analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on AVTR shares. Raymond James Financial lowered Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. Bank of America downgraded shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price objective for the company. in a report on Monday, December 15th. Jefferies Financial Group cut Avantor to an “underperform” rating in a research note on Wednesday, December 17th. JPMorgan Chase & Co. restated a “neutral” rating and set a $12.00 price objective (down previously from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Finally, Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $13.60.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.